Botatox 100 – Refined Botulinum Toxin Type A for Reliable Aesthetic and Medical Use
1. Overview & Manufacturer
Botatox 100 is a botulinum toxin type A product manufactured in South Korea, part of the expanding market of high-quality Korean neurotoxins designed for non-surgical facial rejuvenation and selected therapeutic uses. While still emerging globally, Botatox is gaining attention for its purity, performance, and affordability, making it a competitive option for clinics seeking consistent results without premium brand pricing.
2. Composition & Presentation
Each vial contains 100 units of Clostridium botulinum toxin type A, in lyophilized powder form
Must be reconstituted with 0.9% sterile saline (NaCl) before injection
Manufactured under GMP standards, ensuring safety, potency, and batch-to-batch consistency
Low protein content helps reduce the risk of antibody formation with repeated use
3. Mechanism of Action
Like all botulinum toxins, Botatox works by blocking the release of acetylcholine at the neuromuscular junction. This action:
Temporarily paralyzes the targeted muscles
Reduces muscle movement, leading to a smoother, wrinkle-free appearance
Decreases activity of overactive glands (e.g., sweat glands)
4. Clinical Advantages
 Consistent clinical results with high patient satisfaction
 Onset of action within 3–5 days, with full results visible in 7–10 days
 Effect duration of approximately 3–6 months depending on treatment area and metabolism
 Balanced diffusion profile: suitable for both small, detailed corrections and wider treatment zones
 Cost-effective alternative to major Western brands such as Botox®, Dysport®, and Xeomin®
5. Common Applications
Aesthetic Use:
Forehead lines
Glabellar (frown) lines
Crow’s feet
Bunny lines (nasal wrinkles)
Chin dimpling
Masseter muscle reduction (jaw slimming)
Platysmal bands (neck tightening)
Therapeutic (Off-label) Use:
Hyperhidrosis (underarms, hands, feet)
Temporomandibular joint (TMJ) pain
Bruxism
Chronic migraines
Muscle spasms or facial twitching
6. Handling & Administration
Storage: 2–8°C; avoid light and do not freeze
Reconstitution: Typically 2.0–2.5 mL of 0.9% saline to produce a 4–5 U per 0.1 mL solution
Injection tools: 30–32G insulin syringes for accuracy and patient comfort
Qualified use only: To be administered strictly by licensed medical professionals
7. Safety & Contraindications
Do not use in patients who:
Are pregnant or breastfeeding
Have neuromuscular disorders (e.g., myasthenia gravis)
Are allergic to any botulinum toxin components
Have active skin infections at the injection site
Monitor for potential side effects such as localized swelling, bruising, ptosis (eyelid drooping), or rare systemic effects if overdosed or incorrectly placed.